Sign in
IMVIF Stock Price, Chart, Stats & News
IMV Inc.
Save
IMV Inc. (IMVIF) does not currently pay a dividend.
23,423
Market cap
–
Current P/E
–
Forward P/E
IMVIF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
IMV Inc. is a biopharmaceutical firm focused on immuno-oncology, currently in the clinical development stage. The company leverages its proprietary DPX immune-modulating platform to create a diverse range of treatments aimed at both solid tumors and blood cancers. The flagship therapeutic, maveropepimut-S, is an immunotherapy derived from the DPX platform, specifically engineered to attack cells expressing survivin.
Similar securities
Based on sector and market capitalization
Report issue